African production of mpox vaccines could secure the continent’s health

As Africa grapples with multiple outbreaks of mpox, public health leaders say locally produced vaccines are vital to end donation dependence and secure the continent’s health.

Severity of RSV Hospitalizations Rivals COVID in Older Adults

Hospitalizations for respiratory syncytial virus (RSV) infections were less frequent than those due to influenza or COVID-19 in adults 60 and up, but they were

October 6, 2023

GSK seeks to extend RSV vaccine use in adults aged 50-59 years

Share this article GSK’s RSV vaccine could soon be available for adults aged 50-59 at risk of RSV disease. Credit: GSK plc. The European Medicines

January 30, 2024

Bayer, short on cash, reaches into shareholders’ pockets

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The need-to-know this morning

February 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.